AstraZeneca Pharmaceuticals LP

Registered Principal Details

Business Or Interest:
Research, development and sales of pharmaceuticals

Lobbying Interests:
All matters pertaining to the researching, development marketing, sale and distribution of medications.

CEO Name:
David Brennen
Executive Director

Contact
CB
Christine Barnett
PO Box 15437
Wilmington, DE 19850-5737
(302) 885-5412
(302) 885-1110
christine.barnett@astrazeneca.com
www.astrazeneca.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 12
Assembly Bill 12
relating to: gifts given or offered by prescription drug manufacturers and distributors to encourage practitioners to prescribe certain drugs and providing a penalty.

Bill Text and History

Against
Notification Date
2/27/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 204
Assembly Bill 204
relating to: advertising for prescription drugs.

Bill Text and History

Against
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 40
Senate Bill 40
relating to: state finances and appropriations, constituting the executive budget act of the 2007 legislature.

Bill Text and History

2007 Wisconsin Act 20

None
Notification Date
2/27/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 118
Senate Bill 118
relating to: advertising for prescription drugs.

Bill Text and History

Against
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health and Family Services: Medical Assistance
Biennial budget bill treatment of matter relating to
Health and Family Services: Medical Assistance

Notification Date
2/27/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Health and Family Services: Prescription Drug Assistance
Biennial budget bill treatment of matter relating to
Health and Family Services: Prescription Drug Assistance

Notification Date
2/27/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Medicaid
Development, drafting or introduction of a proposal relating to
Medicaid

Action Intended To Affect
Legislative Matter

Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Medicare
Development, drafting or introduction of a proposal relating to
Medicare

Action Intended To Affect
Legislative Matter

Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Pharmaceutical Companies
Development, drafting or introduction of a proposal relating to
Pharmaceutical Companies

Action Intended To Affect
Legislative Matter

Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2008
January - June
2008
July - December
Total
Total Lobbying Expenditures 2008
January - June
$33,191.60
2008
July - December
$6,854.54
Total $40,046.14
Total Hours Communicating 2008
January - June
89.00
2008
July - December
60.00
Total 149.00
Total Hours Other 2008
January - June
109.50
2008
July - December
86.00
Total 195.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

No legislative bills/resolutions found.

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2007
January - June
2007
July - December
2008
January - June
2008
July - December
Total
2007
January - June
2007
July - December
2008
January - June
25%
2008
July - December
Total 14%
2007
January - June
2007
July - December
2008
January - June
2008
July - December
Total
2007
January - June
2007
July - December
2008
January - June
50%
2008
July - December
Total 29%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2007
January - June
2007
July - December
2008
January - June
2008
July - December
Total
2007
January - June
2007
July - December
2008
January - June
25%
2008
July - December
50%
Total 36%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2007
January - June
2007
July - December
2008
January - June
2008
July - December
Total
2007
January - June
2007
July - December
2008
January - June
2008
July - December
50%
Total 21%

Filed Statements of Lobbying Activity and Expenditures